Is Ceftriaxone + Lidocaine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Ceftriaxone + Lidocaine.

Is Ceftriaxone + Lidocaine approved by the US FDA?

Drugs@FDA lists 1 application product line for Ceftriaxone + Lidocaine, including ROCEPHIN KIT (Discontinued).

Active substances

Ceftriaxone + Lidocaine

SFDA 1
US FDA 1

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
MESPORIN 250 I.M.	250 mg	Powder and solvent for suspension for injection · Intramuscular use	1 Vial	SAR 15.85	Generic · Prescription	ACINO PHARMA AG	Withdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
ROCEPHIN KIT	EQ 1GM BASE/VIAL,N/A;N/A,1%; EQ 500MG BASE/VIAL,N/A;N/A,1%	injectable · injection	HOFFMANN LA ROCHE	Discontinued	21 Dec 1984

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.